Presentazione di PowerPoint

1
(No Transcript)
2
(No Transcript)
3
(No Transcript)
4
(No Transcript)
5
DOTA-TOC
6
DOTA-TOC
7
DOTA-TOC
8
18Ga-DOTA-NOC
9
Restaging of ileum NET treated by S
10
Male, 49yo. Staging of NET, CI liver lesions
11
Female, 51yo. Staging of NET, CT lung liver
lesions
12
Male, 45yo. Restaging of MEN1
13
Male, 57yo. Restaging
14
Female, 29yo. Suspect bronchal carcinoid
15
Somatostatin Receptor PET
18F-DOPA PET
16
Metastatic Bronchal Carcinoid
18F-DOPA
68Ga-DOTA-NOC
17
MEN 1
18F-DOPA
68Ga-DOTA-NOC
18
Metastatic Carcinoid
18F-DOPA
68Ga-DOTA-NOC
19
Pancreatic NET
18F-DOPA
68Ga-DOTA-NOC
20
NUOVI TRACCIANTI PET
INTERESSE ED APPLICAZIONI IN RAPIDA
CRESCITA PROBLEMI LEGATI A NORMATIVE E
DISPONIBILITA DEI TRACCIANTI
21
Somatostatin Receptor PET
More Accurate than CI (incl SRS)
Less Expensive (2 pts/week)
Less Complicated
Predictive of Response to Therapy
22
18F-DOPA PET
Possible in SSR negative tumours
23
GRAZIE